Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      After 12 years of service, Lupin Chief Financial Officer quits to pursue non pharma opportunities

      After 12 years of service, Lupin Chief Financial Officer quits to pursue non pharma opportunities

      Medical Dialogues Bureau28 Nov 2018 4:27 PM IST
      Mumbai: Through a recent release, pharma major Lupin announced the exit of its Chief Financial Officer, Ramesh Swaminathan. The company said in a...
      IMPLANT FILES IMPACT: USFDA plans overhaul of decades-old medical device system

      IMPLANT FILES IMPACT: USFDA plans overhaul of decades-old medical device system

      Medical Dialogues Bureau28 Nov 2018 4:15 PM IST
      New Delhi: US health officials said Monday they plan to overhaul the nation's decades-old medical device system for approving most medical devices,...
      Teva to recall blood pressure medicines containing Valsartan in US

      Teva to recall blood pressure medicines containing Valsartan in US

      Medical Dialogues Bureau28 Nov 2018 4:13 PM IST
      New Delhi: Teva Pharmaceutical Industries Ltd is recalling certain combinations of blood pressure drug valsartan in the United States following the...
      Tarapur facility receives EIR from US FDA: Lupin

      Tarapur facility receives EIR from US FDA: Lupin

      Medical Dialogues Bureau28 Nov 2018 4:08 PM IST
      Mumbai: In a recent press release pharma major Lupin announced the receipt of the Establishment Inspection Report (EIR) on the completion of an...
      Loxo,Bayer gets U.S approval for cancer drug Larotrectinib

      Loxo,Bayer gets U.S approval for cancer drug Larotrectinib

      Medical Dialogues Bureau28 Nov 2018 9:06 AM IST
      New Delhi: A Loxo Oncology Inc drug larotrectinib shown to be effective against a wide variety of cancers driven by a single, rare genetic mutation...
      Sun Pharma to acquire Japan

      Sun Pharma to acquire Japan's Pola Pharma for Rs 7 crores approx

      Medical Dialogues Bureau27 Nov 2018 4:20 PM IST
      New Delhi: Sun Pharma on Monday said it will acquire Japan-based Pola Pharma for around USD 1 million, (approximately Rs 7 crores) to strengthen its...
      ICIJ Implant Files: Medtronic allegedly linked to many breaches

      ICIJ Implant Files: Medtronic allegedly linked to many breaches

      Medical Dialogues Bureau27 Nov 2018 1:23 PM IST
      Washington: A world leader in medical technology, the American firm Medtronic, may be linked to as many as 9,300 deaths and 292,000 injuries in the US...
      Alembic Pharmaceuticals gets USFDA nod for pain relief ointment -Xylocaine

      Alembic Pharmaceuticals gets USFDA nod for pain relief ointment -Xylocaine

      Medical Dialogues Bureau27 Nov 2018 1:19 PM IST
      NEW DELHI: Alembic Pharmaceuticals Monday said its joint venture Aleor Dermaceuticalshas received approval from the US health regulator for Xylocaine...
      Sun Pharmaceutical, subsidiary enter settlements in Modafinil antitrust litigation

      Sun Pharmaceutical, subsidiary enter settlements in Modafinil antitrust litigation

      Medical Dialogues Bureau27 Nov 2018 1:18 PM IST
      New Delhi: Drug major Sun Pharmaceutical Industries on Monday said the company along with its subsidiary has entered into settlements with certain...
      Lupin gets USFDA nod generic Clomipramine Hydrochloride capsules

      Lupin gets USFDA nod generic Clomipramine Hydrochloride capsules

      Medical Dialogues Bureau27 Nov 2018 1:17 PM IST
      New Delhi: Drug firm Lupin on Monday said it has received approvals from the US health regulator for its Clomipramine Hydrochloride capsules, and...
      Merck appoints Jasper Bos as Managing Director of venture capital arm M Ventures

      Merck appoints Jasper Bos as Managing Director of venture capital arm M Ventures

      Medical Dialogues Bureau26 Nov 2018 2:11 PM IST
      Germany: Merck, in their recent press release announced the appointment of Jasper Bos as the new Managing Director of its strategic corporate venture...
      Indian biosimilar market to be worth USD 40 billion by 2030: CII report

      Indian biosimilar market to be worth USD 40 billion by 2030: CII report

      Medical Dialogues Bureau26 Nov 2018 2:01 PM IST
      Mumbai: The Confederation of Indian Industry (CII) & Sathguru Management Consultants(SMC) released a position paper on Indian Biosimilars Industry...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok